nodes	percent_of_prediction	percent_of_DWPC	metapath
Metolazone—Pancreatitis—Simvastatin—atherosclerosis	0.0052	0.00533	CcSEcCtD
Metolazone—Photosensitivity reaction—Lovastatin—atherosclerosis	0.00517	0.00531	CcSEcCtD
Metolazone—Dry skin—Niacin—atherosclerosis	0.00516	0.0053	CcSEcCtD
Metolazone—Orthostatic hypotension—Niacin—atherosclerosis	0.00515	0.00528	CcSEcCtD
Metolazone—Erectile dysfunction—Ezetimibe—atherosclerosis	0.00512	0.00525	CcSEcCtD
Metolazone—Dry skin—Pravastatin—atherosclerosis	0.00508	0.00522	CcSEcCtD
Metolazone—Abdominal discomfort—Simvastatin—atherosclerosis	0.00508	0.00522	CcSEcCtD
Metolazone—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.00508	0.00521	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.00501	0.00514	CcSEcCtD
Metolazone—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.00499	0.00513	CcSEcCtD
Metolazone—Cramp muscle—Pravastatin—atherosclerosis	0.00499	0.00513	CcSEcCtD
Metolazone—Neuropathy peripheral—Lovastatin—atherosclerosis	0.00495	0.00508	CcSEcCtD
Metolazone—Abdominal distension—Niacin—atherosclerosis	0.0049	0.00503	CcSEcCtD
Metolazone—Erectile dysfunction—Simvastatin—atherosclerosis	0.00488	0.00501	CcSEcCtD
Metolazone—Neuropathy peripheral—Ezetimibe—atherosclerosis	0.00486	0.00499	CcSEcCtD
Metolazone—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00484	0.00497	CcSEcCtD
Metolazone—Abdominal distension—Pravastatin—atherosclerosis	0.00483	0.00495	CcSEcCtD
Metolazone—Pancreatitis—Pravastatin—atherosclerosis	0.0047	0.00482	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.00469	0.00481	CcSEcCtD
Metolazone—Neuropathy peripheral—Simvastatin—atherosclerosis	0.00463	0.00476	CcSEcCtD
Metolazone—Flatulence—Rosuvastatin—atherosclerosis	0.00459	0.00471	CcSEcCtD
Metolazone—Hepatitis—Lovastatin—atherosclerosis	0.00454	0.00466	CcSEcCtD
Metolazone—Erectile dysfunction—Niacin—atherosclerosis	0.00448	0.0046	CcSEcCtD
Metolazone—Hepatitis—Ezetimibe—atherosclerosis	0.00445	0.00457	CcSEcCtD
Metolazone—Erectile dysfunction—Pravastatin—atherosclerosis	0.00442	0.00453	CcSEcCtD
Metolazone—Photosensitivity reaction—Pravastatin—atherosclerosis	0.00438	0.00449	CcSEcCtD
Metolazone—Erythema multiforme—Lovastatin—atherosclerosis	0.00429	0.0044	CcSEcCtD
Metolazone—Hepatitis—Simvastatin—atherosclerosis	0.00424	0.00436	CcSEcCtD
Metolazone—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.00424	0.00435	CcSEcCtD
Metolazone—Erythema multiforme—Ezetimibe—atherosclerosis	0.00421	0.00432	CcSEcCtD
Metolazone—Neuropathy peripheral—Pravastatin—atherosclerosis	0.00419	0.0043	CcSEcCtD
Metolazone—Chills—Lovastatin—atherosclerosis	0.00407	0.00418	CcSEcCtD
Metolazone—Cough—Rosuvastatin—atherosclerosis	0.00407	0.00417	CcSEcCtD
Metolazone—Erythema multiforme—Simvastatin—atherosclerosis	0.00401	0.00412	CcSEcCtD
Metolazone—Arthralgia—Rosuvastatin—atherosclerosis	0.00397	0.00407	CcSEcCtD
Metolazone—Hepatitis—Niacin—atherosclerosis	0.0039	0.004	CcSEcCtD
Metolazone—Flatulence—Lovastatin—atherosclerosis	0.00389	0.00399	CcSEcCtD
Metolazone—Dysgeusia—Lovastatin—atherosclerosis	0.00387	0.00397	CcSEcCtD
Metolazone—Hepatitis—Pravastatin—atherosclerosis	0.00384	0.00394	CcSEcCtD
Metolazone—Back pain—Lovastatin—atherosclerosis	0.00382	0.00392	CcSEcCtD
Metolazone—Flatulence—Ezetimibe—atherosclerosis	0.00382	0.00392	CcSEcCtD
Metolazone—Chills—Simvastatin—atherosclerosis	0.00381	0.00391	CcSEcCtD
Metolazone—Muscle spasms—Lovastatin—atherosclerosis	0.0038	0.0039	CcSEcCtD
Metolazone—Back pain—Ezetimibe—atherosclerosis	0.00375	0.00385	CcSEcCtD
Metolazone—Muscle spasms—Ezetimibe—atherosclerosis	0.00372	0.00382	CcSEcCtD
Metolazone—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.00372	0.00382	CcSEcCtD
Metolazone—Vision blurred—Lovastatin—atherosclerosis	0.00372	0.00382	CcSEcCtD
Metolazone—Ill-defined disorder—Lovastatin—atherosclerosis	0.00367	0.00376	CcSEcCtD
Metolazone—Flatulence—Simvastatin—atherosclerosis	0.00364	0.00374	CcSEcCtD
Metolazone—Tinnitus—Niacin—atherosclerosis	0.00363	0.00373	CcSEcCtD
Metolazone—Erythema multiforme—Pravastatin—atherosclerosis	0.00363	0.00372	CcSEcCtD
Metolazone—Dysgeusia—Simvastatin—atherosclerosis	0.00362	0.00371	CcSEcCtD
Metolazone—Ill-defined disorder—Ezetimibe—atherosclerosis	0.00359	0.00369	CcSEcCtD
Metolazone—Anaemia—Ezetimibe—atherosclerosis	0.00358	0.00367	CcSEcCtD
Metolazone—Tinnitus—Pravastatin—atherosclerosis	0.00358	0.00367	CcSEcCtD
Metolazone—Malaise—Lovastatin—atherosclerosis	0.00356	0.00366	CcSEcCtD
Metolazone—Muscle spasms—Simvastatin—atherosclerosis	0.00355	0.00364	CcSEcCtD
Metolazone—Vertigo—Lovastatin—atherosclerosis	0.00355	0.00364	CcSEcCtD
Metolazone—Leukopenia—Lovastatin—atherosclerosis	0.00354	0.00363	CcSEcCtD
Metolazone—Chills—Niacin—atherosclerosis	0.0035	0.00359	CcSEcCtD
Metolazone—Malaise—Ezetimibe—atherosclerosis	0.00349	0.00359	CcSEcCtD
Metolazone—Vision blurred—Simvastatin—atherosclerosis	0.00348	0.00357	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.00347	0.00356	CcSEcCtD
Metolazone—Chills—Pravastatin—atherosclerosis	0.00344	0.00353	CcSEcCtD
Metolazone—Insomnia—Rosuvastatin—atherosclerosis	0.00344	0.00353	CcSEcCtD
Metolazone—Ill-defined disorder—Simvastatin—atherosclerosis	0.00343	0.00352	CcSEcCtD
Metolazone—Palpitations—Ezetimibe—atherosclerosis	0.00342	0.00351	CcSEcCtD
Metolazone—Paraesthesia—Rosuvastatin—atherosclerosis	0.00342	0.0035	CcSEcCtD
Metolazone—Anaemia—Simvastatin—atherosclerosis	0.00341	0.0035	CcSEcCtD
Metolazone—Cough—Ezetimibe—atherosclerosis	0.00338	0.00347	CcSEcCtD
Metolazone—Arthralgia—Lovastatin—atherosclerosis	0.00336	0.00345	CcSEcCtD
Metolazone—Chest pain—Lovastatin—atherosclerosis	0.00336	0.00345	CcSEcCtD
Metolazone—Anxiety—Lovastatin—atherosclerosis	0.00335	0.00344	CcSEcCtD
Metolazone—Dyspepsia—Rosuvastatin—atherosclerosis	0.00335	0.00344	CcSEcCtD
Metolazone—Hypertension—Ezetimibe—atherosclerosis	0.00334	0.00343	CcSEcCtD
Metolazone—Flatulence—Niacin—atherosclerosis	0.00334	0.00343	CcSEcCtD
Metolazone—Malaise—Simvastatin—atherosclerosis	0.00333	0.00342	CcSEcCtD
Metolazone—Tension—Niacin—atherosclerosis	0.00333	0.00342	CcSEcCtD
Metolazone—Discomfort—Lovastatin—atherosclerosis	0.00332	0.00341	CcSEcCtD
Metolazone—Vertigo—Simvastatin—atherosclerosis	0.00332	0.00341	CcSEcCtD
Metolazone—Leukopenia—Simvastatin—atherosclerosis	0.00331	0.00339	CcSEcCtD
Metolazone—Chest pain—Ezetimibe—atherosclerosis	0.0033	0.00338	CcSEcCtD
Metolazone—Arthralgia—Ezetimibe—atherosclerosis	0.0033	0.00338	CcSEcCtD
Metolazone—Nervousness—Niacin—atherosclerosis	0.0033	0.00338	CcSEcCtD
Metolazone—Flatulence—Pravastatin—atherosclerosis	0.00329	0.00338	CcSEcCtD
Metolazone—Dry mouth—Lovastatin—atherosclerosis	0.00329	0.00337	CcSEcCtD
Metolazone—Tension—Pravastatin—atherosclerosis	0.00328	0.00336	CcSEcCtD
Metolazone—Dysgeusia—Pravastatin—atherosclerosis	0.00327	0.00336	CcSEcCtD
Metolazone—Muscle spasms—Niacin—atherosclerosis	0.00326	0.00335	CcSEcCtD
Metolazone—Discomfort—Ezetimibe—atherosclerosis	0.00326	0.00334	CcSEcCtD
Metolazone—Constipation—Rosuvastatin—atherosclerosis	0.00325	0.00334	CcSEcCtD
Metolazone—Pain—Rosuvastatin—atherosclerosis	0.00325	0.00334	CcSEcCtD
Metolazone—Nervousness—Pravastatin—atherosclerosis	0.00324	0.00333	CcSEcCtD
Metolazone—Dry mouth—Ezetimibe—atherosclerosis	0.00323	0.00331	CcSEcCtD
Metolazone—Muscle spasms—Pravastatin—atherosclerosis	0.00321	0.0033	CcSEcCtD
Metolazone—Vision blurred—Niacin—atherosclerosis	0.0032	0.00328	CcSEcCtD
Metolazone—Thrombocytopenia—Lovastatin—atherosclerosis	0.00316	0.00324	CcSEcCtD
Metolazone—Vision blurred—Pravastatin—atherosclerosis	0.00315	0.00323	CcSEcCtD
Metolazone—Arthralgia—Simvastatin—atherosclerosis	0.00315	0.00323	CcSEcCtD
Metolazone—Chest pain—Simvastatin—atherosclerosis	0.00315	0.00323	CcSEcCtD
Metolazone—Feeling abnormal—Rosuvastatin—atherosclerosis	0.00313	0.00322	CcSEcCtD
Metolazone—Anxiety—Simvastatin—atherosclerosis	0.00313	0.00322	CcSEcCtD
Metolazone—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.00311	0.00319	CcSEcCtD
Metolazone—Discomfort—Simvastatin—atherosclerosis	0.00311	0.00319	CcSEcCtD
Metolazone—Ill-defined disorder—Pravastatin—atherosclerosis	0.0031	0.00318	CcSEcCtD
Metolazone—Thrombocytopenia—Ezetimibe—atherosclerosis	0.0031	0.00318	CcSEcCtD
Metolazone—Anaemia—Pravastatin—atherosclerosis	0.00309	0.00317	CcSEcCtD
Metolazone—Anorexia—Lovastatin—atherosclerosis	0.00307	0.00315	CcSEcCtD
Metolazone—Vertigo—Niacin—atherosclerosis	0.00305	0.00313	CcSEcCtD
Metolazone—Syncope—Niacin—atherosclerosis	0.00304	0.00312	CcSEcCtD
Metolazone—Leukopenia—Niacin—atherosclerosis	0.00304	0.00312	CcSEcCtD
Metolazone—Urticaria—Rosuvastatin—atherosclerosis	0.00302	0.0031	CcSEcCtD
Metolazone—Malaise—Pravastatin—atherosclerosis	0.00301	0.00309	CcSEcCtD
Metolazone—Abdominal pain—Rosuvastatin—atherosclerosis	0.00301	0.00309	CcSEcCtD
Metolazone—Vertigo—Pravastatin—atherosclerosis	0.003	0.00308	CcSEcCtD
Metolazone—Palpitations—Niacin—atherosclerosis	0.003	0.00308	CcSEcCtD
Metolazone—Leukopenia—Pravastatin—atherosclerosis	0.00299	0.00307	CcSEcCtD
Metolazone—Loss of consciousness—Niacin—atherosclerosis	0.00298	0.00306	CcSEcCtD
Metolazone—Cough—Niacin—atherosclerosis	0.00296	0.00304	CcSEcCtD
Metolazone—Thrombocytopenia—Simvastatin—atherosclerosis	0.00295	0.00303	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.00294	0.00301	CcSEcCtD
Metolazone—Insomnia—Lovastatin—atherosclerosis	0.00292	0.00299	CcSEcCtD
Metolazone—Cough—Pravastatin—atherosclerosis	0.00291	0.00299	CcSEcCtD
Metolazone—Paraesthesia—Lovastatin—atherosclerosis	0.00289	0.00297	CcSEcCtD
Metolazone—Arthralgia—Niacin—atherosclerosis	0.00289	0.00296	CcSEcCtD
Metolazone—Hypertension—Pravastatin—atherosclerosis	0.00288	0.00296	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.00288	0.00296	CcSEcCtD
Metolazone—Anorexia—Simvastatin—atherosclerosis	0.00287	0.00295	CcSEcCtD
Metolazone—Insomnia—Ezetimibe—atherosclerosis	0.00286	0.00293	CcSEcCtD
Metolazone—Chest pain—Pravastatin—atherosclerosis	0.00284	0.00292	CcSEcCtD
Metolazone—Arthralgia—Pravastatin—atherosclerosis	0.00284	0.00292	CcSEcCtD
Metolazone—Paraesthesia—Ezetimibe—atherosclerosis	0.00284	0.00291	CcSEcCtD
Metolazone—Dyspepsia—Lovastatin—atherosclerosis	0.00284	0.00291	CcSEcCtD
Metolazone—Anxiety—Pravastatin—atherosclerosis	0.00283	0.00291	CcSEcCtD
Metolazone—Dry mouth—Niacin—atherosclerosis	0.00282	0.0029	CcSEcCtD
Metolazone—Discomfort—Pravastatin—atherosclerosis	0.00281	0.00288	CcSEcCtD
Metolazone—Hypersensitivity—Rosuvastatin—atherosclerosis	0.0028	0.00288	CcSEcCtD
Metolazone—Decreased appetite—Lovastatin—atherosclerosis	0.0028	0.00288	CcSEcCtD
Metolazone—Dyspepsia—Ezetimibe—atherosclerosis	0.00278	0.00286	CcSEcCtD
Metolazone—Fatigue—Lovastatin—atherosclerosis	0.00278	0.00285	CcSEcCtD
Metolazone—Constipation—Lovastatin—atherosclerosis	0.00276	0.00283	CcSEcCtD
Metolazone—Pain—Lovastatin—atherosclerosis	0.00276	0.00283	CcSEcCtD
Metolazone—Decreased appetite—Ezetimibe—atherosclerosis	0.00275	0.00282	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.00275	0.00282	CcSEcCtD
Metolazone—Asthenia—Rosuvastatin—atherosclerosis	0.00273	0.0028	CcSEcCtD
Metolazone—Insomnia—Simvastatin—atherosclerosis	0.00273	0.0028	CcSEcCtD
Metolazone—Fatigue—Ezetimibe—atherosclerosis	0.00273	0.0028	CcSEcCtD
Metolazone—Shock—Niacin—atherosclerosis	0.00272	0.0028	CcSEcCtD
Metolazone—Paraesthesia—Simvastatin—atherosclerosis	0.00271	0.00278	CcSEcCtD
Metolazone—Constipation—Ezetimibe—atherosclerosis	0.0027	0.00277	CcSEcCtD
Metolazone—Pain—Ezetimibe—atherosclerosis	0.0027	0.00277	CcSEcCtD
Metolazone—Pruritus—Rosuvastatin—atherosclerosis	0.00269	0.00276	CcSEcCtD
Metolazone—Thrombocytopenia—Pravastatin—atherosclerosis	0.00267	0.00274	CcSEcCtD
Metolazone—Feeling abnormal—Lovastatin—atherosclerosis	0.00266	0.00273	CcSEcCtD
Metolazone—Dyspepsia—Simvastatin—atherosclerosis	0.00265	0.00272	CcSEcCtD
Metolazone—Anorexia—Niacin—atherosclerosis	0.00264	0.00271	CcSEcCtD
Metolazone—Gastrointestinal pain—Lovastatin—atherosclerosis	0.00264	0.0027	CcSEcCtD
Metolazone—Decreased appetite—Simvastatin—atherosclerosis	0.00262	0.00269	CcSEcCtD
Metolazone—Feeling abnormal—Ezetimibe—atherosclerosis	0.00261	0.00267	CcSEcCtD
Metolazone—Diarrhoea—Rosuvastatin—atherosclerosis	0.0026	0.00267	CcSEcCtD
Metolazone—Fatigue—Simvastatin—atherosclerosis	0.0026	0.00267	CcSEcCtD
Metolazone—Anorexia—Pravastatin—atherosclerosis	0.0026	0.00267	CcSEcCtD
Metolazone—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.00259	0.00265	CcSEcCtD
Metolazone—Pain—Simvastatin—atherosclerosis	0.00258	0.00265	CcSEcCtD
Metolazone—Constipation—Simvastatin—atherosclerosis	0.00258	0.00265	CcSEcCtD
Metolazone—Urticaria—Lovastatin—atherosclerosis	0.00256	0.00263	CcSEcCtD
Metolazone—Abdominal pain—Lovastatin—atherosclerosis	0.00255	0.00261	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Niacin—atherosclerosis	0.00252	0.00259	CcSEcCtD
Metolazone—Dizziness—Rosuvastatin—atherosclerosis	0.00252	0.00258	CcSEcCtD
Metolazone—Urticaria—Ezetimibe—atherosclerosis	0.00251	0.00258	CcSEcCtD
Metolazone—Insomnia—Niacin—atherosclerosis	0.0025	0.00257	CcSEcCtD
Metolazone—Abdominal pain—Ezetimibe—atherosclerosis	0.0025	0.00256	CcSEcCtD
Metolazone—Paraesthesia—Niacin—atherosclerosis	0.00249	0.00255	CcSEcCtD
Metolazone—Feeling abnormal—Simvastatin—atherosclerosis	0.00248	0.00255	CcSEcCtD
Metolazone—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.00248	0.00255	CcSEcCtD
Metolazone—Gastrointestinal pain—Simvastatin—atherosclerosis	0.00247	0.00253	CcSEcCtD
Metolazone—Insomnia—Pravastatin—atherosclerosis	0.00247	0.00253	CcSEcCtD
Metolazone—Somnolence—Niacin—atherosclerosis	0.00246	0.00253	CcSEcCtD
Metolazone—Paraesthesia—Pravastatin—atherosclerosis	0.00245	0.00251	CcSEcCtD
Metolazone—Dyspepsia—Niacin—atherosclerosis	0.00244	0.0025	CcSEcCtD
Metolazone—Decreased appetite—Niacin—atherosclerosis	0.00241	0.00247	CcSEcCtD
Metolazone—Dyspepsia—Pravastatin—atherosclerosis	0.0024	0.00246	CcSEcCtD
Metolazone—Rash—Rosuvastatin—atherosclerosis	0.0024	0.00246	CcSEcCtD
Metolazone—Dermatitis—Rosuvastatin—atherosclerosis	0.0024	0.00246	CcSEcCtD
Metolazone—Urticaria—Simvastatin—atherosclerosis	0.0024	0.00246	CcSEcCtD
Metolazone—Abdominal pain—Simvastatin—atherosclerosis	0.00238	0.00245	CcSEcCtD
Metolazone—Headache—Rosuvastatin—atherosclerosis	0.00238	0.00245	CcSEcCtD
Metolazone—Hypersensitivity—Lovastatin—atherosclerosis	0.00238	0.00244	CcSEcCtD
Metolazone—Decreased appetite—Pravastatin—atherosclerosis	0.00237	0.00243	CcSEcCtD
Metolazone—Pain—Niacin—atherosclerosis	0.00237	0.00243	CcSEcCtD
Metolazone—Fatigue—Pravastatin—atherosclerosis	0.00235	0.00241	CcSEcCtD
Metolazone—Pain—Pravastatin—atherosclerosis	0.00233	0.00239	CcSEcCtD
Metolazone—Constipation—Pravastatin—atherosclerosis	0.00233	0.00239	CcSEcCtD
Metolazone—Hypersensitivity—Ezetimibe—atherosclerosis	0.00233	0.00239	CcSEcCtD
Metolazone—Asthenia—Lovastatin—atherosclerosis	0.00231	0.00237	CcSEcCtD
Metolazone—Pruritus—Lovastatin—atherosclerosis	0.00228	0.00234	CcSEcCtD
Metolazone—Asthenia—Ezetimibe—atherosclerosis	0.00227	0.00233	CcSEcCtD
Metolazone—Gastrointestinal pain—Niacin—atherosclerosis	0.00226	0.00232	CcSEcCtD
Metolazone—Nausea—Rosuvastatin—atherosclerosis	0.00226	0.00232	CcSEcCtD
Metolazone—Feeling abnormal—Pravastatin—atherosclerosis	0.00225	0.00231	CcSEcCtD
Metolazone—Pruritus—Ezetimibe—atherosclerosis	0.00224	0.0023	CcSEcCtD
Metolazone—Gastrointestinal pain—Pravastatin—atherosclerosis	0.00223	0.00229	CcSEcCtD
Metolazone—Hypersensitivity—Simvastatin—atherosclerosis	0.00222	0.00228	CcSEcCtD
Metolazone—Diarrhoea—Lovastatin—atherosclerosis	0.00221	0.00226	CcSEcCtD
Metolazone—Urticaria—Niacin—atherosclerosis	0.0022	0.00226	CcSEcCtD
Metolazone—Abdominal pain—Niacin—atherosclerosis	0.00219	0.00225	CcSEcCtD
Metolazone—Urticaria—Pravastatin—atherosclerosis	0.00217	0.00222	CcSEcCtD
Metolazone—Asthenia—Simvastatin—atherosclerosis	0.00216	0.00222	CcSEcCtD
Metolazone—Diarrhoea—Ezetimibe—atherosclerosis	0.00216	0.00222	CcSEcCtD
Metolazone—Abdominal pain—Pravastatin—atherosclerosis	0.00216	0.00221	CcSEcCtD
Metolazone—Pruritus—Simvastatin—atherosclerosis	0.00213	0.00219	CcSEcCtD
Metolazone—Dizziness—Lovastatin—atherosclerosis	0.00213	0.00219	CcSEcCtD
Metolazone—Dizziness—Ezetimibe—atherosclerosis	0.00209	0.00215	CcSEcCtD
Metolazone—Diarrhoea—Simvastatin—atherosclerosis	0.00206	0.00212	CcSEcCtD
Metolazone—Vomiting—Lovastatin—atherosclerosis	0.00205	0.0021	CcSEcCtD
Metolazone—Hypersensitivity—Niacin—atherosclerosis	0.00204	0.00209	CcSEcCtD
Metolazone—Rash—Lovastatin—atherosclerosis	0.00203	0.00209	CcSEcCtD
Metolazone—Dermatitis—Lovastatin—atherosclerosis	0.00203	0.00208	CcSEcCtD
Metolazone—Headache—Lovastatin—atherosclerosis	0.00202	0.00207	CcSEcCtD
Metolazone—Vomiting—Ezetimibe—atherosclerosis	0.00201	0.00206	CcSEcCtD
Metolazone—Hypersensitivity—Pravastatin—atherosclerosis	0.00201	0.00206	CcSEcCtD
Metolazone—Dizziness—Simvastatin—atherosclerosis	0.00199	0.00205	CcSEcCtD
Metolazone—Rash—Ezetimibe—atherosclerosis	0.00199	0.00205	CcSEcCtD
Metolazone—Dermatitis—Ezetimibe—atherosclerosis	0.00199	0.00204	CcSEcCtD
Metolazone—Asthenia—Niacin—atherosclerosis	0.00199	0.00204	CcSEcCtD
Metolazone—Headache—Ezetimibe—atherosclerosis	0.00198	0.00203	CcSEcCtD
Metolazone—Pruritus—Niacin—atherosclerosis	0.00196	0.00201	CcSEcCtD
Metolazone—Asthenia—Pravastatin—atherosclerosis	0.00196	0.00201	CcSEcCtD
Metolazone—Pruritus—Pravastatin—atherosclerosis	0.00193	0.00198	CcSEcCtD
Metolazone—Vomiting—Simvastatin—atherosclerosis	0.00192	0.00197	CcSEcCtD
Metolazone—Nausea—Lovastatin—atherosclerosis	0.00191	0.00196	CcSEcCtD
Metolazone—Rash—Simvastatin—atherosclerosis	0.0019	0.00195	CcSEcCtD
Metolazone—Dermatitis—Simvastatin—atherosclerosis	0.0019	0.00195	CcSEcCtD
Metolazone—Diarrhoea—Niacin—atherosclerosis	0.00189	0.00194	CcSEcCtD
Metolazone—Headache—Simvastatin—atherosclerosis	0.00189	0.00194	CcSEcCtD
Metolazone—Nausea—Ezetimibe—atherosclerosis	0.00188	0.00193	CcSEcCtD
Metolazone—Diarrhoea—Pravastatin—atherosclerosis	0.00187	0.00191	CcSEcCtD
Metolazone—Dizziness—Niacin—atherosclerosis	0.00183	0.00188	CcSEcCtD
Metolazone—Dizziness—Pravastatin—atherosclerosis	0.0018	0.00185	CcSEcCtD
Metolazone—Nausea—Simvastatin—atherosclerosis	0.00179	0.00184	CcSEcCtD
Metolazone—Vomiting—Niacin—atherosclerosis	0.00176	0.00181	CcSEcCtD
Metolazone—Rash—Niacin—atherosclerosis	0.00175	0.00179	CcSEcCtD
Metolazone—Dermatitis—Niacin—atherosclerosis	0.00174	0.00179	CcSEcCtD
Metolazone—Headache—Niacin—atherosclerosis	0.00173	0.00178	CcSEcCtD
Metolazone—Vomiting—Pravastatin—atherosclerosis	0.00173	0.00178	CcSEcCtD
Metolazone—Rash—Pravastatin—atherosclerosis	0.00172	0.00176	CcSEcCtD
Metolazone—Dermatitis—Pravastatin—atherosclerosis	0.00172	0.00176	CcSEcCtD
Metolazone—Headache—Pravastatin—atherosclerosis	0.00171	0.00175	CcSEcCtD
Metolazone—Nausea—Niacin—atherosclerosis	0.00164	0.00169	CcSEcCtD
Metolazone—Nausea—Pravastatin—atherosclerosis	0.00162	0.00166	CcSEcCtD
Metolazone—CA5A—Metabolism—ABCG5—atherosclerosis	0.000105	0.00414	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP7A1—atherosclerosis	0.000105	0.00413	CbGpPWpGaD
Metolazone—CA7—Metabolism—CYP27A1—atherosclerosis	0.000105	0.00412	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CYP27A1—atherosclerosis	0.000105	0.00412	CbGpPWpGaD
Metolazone—CA5A—Metabolism—LPA—atherosclerosis	0.000102	0.004	CbGpPWpGaD
Metolazone—CA9—HIF-1-alpha transcription factor network—AKT1—atherosclerosis	9.97e-05	0.00392	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—PLG—atherosclerosis	9.96e-05	0.00392	CbGpPWpGaD
Metolazone—CA5B—Metabolism—APOA2—atherosclerosis	9.94e-05	0.00391	CbGpPWpGaD
Metolazone—CA7—Metabolism—PLA2G2A—atherosclerosis	9.94e-05	0.00391	CbGpPWpGaD
Metolazone—CA7—Metabolism—APOA2—atherosclerosis	9.94e-05	0.00391	CbGpPWpGaD
Metolazone—CA7—Metabolism—ALOX15—atherosclerosis	9.94e-05	0.00391	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ALOX15—atherosclerosis	9.94e-05	0.00391	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ALOX5AP—atherosclerosis	9.94e-05	0.00391	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PLA2G2A—atherosclerosis	9.94e-05	0.00391	CbGpPWpGaD
Metolazone—CA7—Metabolism—ALOX5AP—atherosclerosis	9.94e-05	0.00391	CbGpPWpGaD
Metolazone—CA5A—Metabolism—BGN—atherosclerosis	9.84e-05	0.00387	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ABCG5—atherosclerosis	9.82e-05	0.00386	CbGpPWpGaD
Metolazone—CA7—Metabolism—ABCG5—atherosclerosis	9.82e-05	0.00386	CbGpPWpGaD
Metolazone—CA5A—Metabolism—APOA5—atherosclerosis	9.74e-05	0.00383	CbGpPWpGaD
Metolazone—CA12—Metabolism—CYP27A1—atherosclerosis	9.72e-05	0.00382	CbGpPWpGaD
Metolazone—CA7—Metabolism—LPA—atherosclerosis	9.49e-05	0.00373	CbGpPWpGaD
Metolazone—CA5B—Metabolism—LPA—atherosclerosis	9.49e-05	0.00373	CbGpPWpGaD
Metolazone—CA9—Metabolism—LTA4H—atherosclerosis	9.45e-05	0.00372	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCG8—atherosclerosis	9.45e-05	0.00372	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PLA2G1B—atherosclerosis	9.38e-05	0.00369	CbGpPWpGaD
Metolazone—CA4—Metabolism—ABCG1—atherosclerosis	9.25e-05	0.00364	CbGpPWpGaD
Metolazone—CA12—Metabolism—ALOX5AP—atherosclerosis	9.21e-05	0.00362	CbGpPWpGaD
Metolazone—CA12—Metabolism—PLA2G2A—atherosclerosis	9.21e-05	0.00362	CbGpPWpGaD
Metolazone—CA12—Metabolism—ALOX15—atherosclerosis	9.21e-05	0.00362	CbGpPWpGaD
Metolazone—CA12—Metabolism—APOA2—atherosclerosis	9.21e-05	0.00362	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—HMOX1—atherosclerosis	9.19e-05	0.00362	CbGpPWpGaD
Metolazone—CA7—Metabolism—BGN—atherosclerosis	9.19e-05	0.00361	CbGpPWpGaD
Metolazone—CA5B—Metabolism—BGN—atherosclerosis	9.19e-05	0.00361	CbGpPWpGaD
Metolazone—CA12—Metabolism—ABCG5—atherosclerosis	9.1e-05	0.00358	CbGpPWpGaD
Metolazone—CA7—Metabolism—APOA5—atherosclerosis	9.09e-05	0.00358	CbGpPWpGaD
Metolazone—CA5B—Metabolism—APOA5—atherosclerosis	9.09e-05	0.00358	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ALOX5—atherosclerosis	9.06e-05	0.00356	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—APOB—atherosclerosis	8.81e-05	0.00346	CbGpPWpGaD
Metolazone—CA12—Metabolism—LPA—atherosclerosis	8.79e-05	0.00346	CbGpPWpGaD
Metolazone—CA7—Metabolism—PLA2G1B—atherosclerosis	8.75e-05	0.00344	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PLA2G1B—atherosclerosis	8.75e-05	0.00344	CbGpPWpGaD
Metolazone—CA4—Metabolism—FABP4—atherosclerosis	8.69e-05	0.00342	CbGpPWpGaD
Metolazone—CA4—Metabolism—LCAT—atherosclerosis	8.69e-05	0.00342	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOA4—atherosclerosis	8.53e-05	0.00336	CbGpPWpGaD
Metolazone—CA12—Metabolism—BGN—atherosclerosis	8.51e-05	0.00335	CbGpPWpGaD
Metolazone—CA7—Metabolism—ALOX5—atherosclerosis	8.45e-05	0.00332	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ALOX5—atherosclerosis	8.45e-05	0.00332	CbGpPWpGaD
Metolazone—CA12—Metabolism—APOA5—atherosclerosis	8.43e-05	0.00331	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP7A1—atherosclerosis	8.38e-05	0.0033	CbGpPWpGaD
Metolazone—CA5A—Metabolism—NAMPT—atherosclerosis	8.12e-05	0.00319	CbGpPWpGaD
Metolazone—CA12—Metabolism—PLA2G1B—atherosclerosis	8.11e-05	0.00319	CbGpPWpGaD
Metolazone—CA5A—Metabolism—LIPC—atherosclerosis	8.07e-05	0.00317	CbGpPWpGaD
Metolazone—CA5A—Metabolism—APOC3—atherosclerosis	8.02e-05	0.00315	CbGpPWpGaD
Metolazone—CA5A—Metabolism—LDLR—atherosclerosis	7.97e-05	0.00314	CbGpPWpGaD
Metolazone—CA12—Metabolism—ALOX5—atherosclerosis	7.83e-05	0.00308	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CETP—atherosclerosis	7.79e-05	0.00306	CbGpPWpGaD
Metolazone—CA4—Metabolism—CYP27A1—atherosclerosis	7.75e-05	0.00305	CbGpPWpGaD
Metolazone—CA7—Metabolism—NAMPT—atherosclerosis	7.58e-05	0.00298	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NAMPT—atherosclerosis	7.58e-05	0.00298	CbGpPWpGaD
Metolazone—CA7—Metabolism—LIPC—atherosclerosis	7.54e-05	0.00296	CbGpPWpGaD
Metolazone—CA5B—Metabolism—LIPC—atherosclerosis	7.54e-05	0.00296	CbGpPWpGaD
Metolazone—CA5B—Metabolism—APOC3—atherosclerosis	7.49e-05	0.00295	CbGpPWpGaD
Metolazone—CA7—Metabolism—APOC3—atherosclerosis	7.49e-05	0.00295	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCG1—atherosclerosis	7.47e-05	0.00294	CbGpPWpGaD
Metolazone—CA5A—Metabolism—SCARB1—atherosclerosis	7.46e-05	0.00293	CbGpPWpGaD
Metolazone—CA7—Metabolism—LDLR—atherosclerosis	7.44e-05	0.00293	CbGpPWpGaD
Metolazone—CA5B—Metabolism—LDLR—atherosclerosis	7.44e-05	0.00293	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—PPARA—atherosclerosis	7.43e-05	0.00292	CbGpPWpGaD
Metolazone—CA4—Metabolism—PLA2G2A—atherosclerosis	7.35e-05	0.00289	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOA2—atherosclerosis	7.35e-05	0.00289	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALOX15—atherosclerosis	7.35e-05	0.00289	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALOX5AP—atherosclerosis	7.35e-05	0.00289	CbGpPWpGaD
Metolazone—CA7—Metabolism—CETP—atherosclerosis	7.27e-05	0.00286	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CETP—atherosclerosis	7.27e-05	0.00286	CbGpPWpGaD
Metolazone—CA4—Metabolism—ABCG5—atherosclerosis	7.26e-05	0.00285	CbGpPWpGaD
Metolazone—CA5A—Metabolism—HMGCR—atherosclerosis	7.04e-05	0.00277	CbGpPWpGaD
Metolazone—CA12—Metabolism—NAMPT—atherosclerosis	7.03e-05	0.00276	CbGpPWpGaD
Metolazone—CA9—Metabolism—LCAT—atherosclerosis	7.03e-05	0.00276	CbGpPWpGaD
Metolazone—CA9—Metabolism—FABP4—atherosclerosis	7.03e-05	0.00276	CbGpPWpGaD
Metolazone—CA4—Metabolism—LPA—atherosclerosis	7.01e-05	0.00276	CbGpPWpGaD
Metolazone—CA12—Metabolism—LIPC—atherosclerosis	6.98e-05	0.00275	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—APOA1—atherosclerosis	6.97e-05	0.00274	CbGpPWpGaD
Metolazone—CA7—Metabolism—SCARB1—atherosclerosis	6.96e-05	0.00274	CbGpPWpGaD
Metolazone—CA5B—Metabolism—SCARB1—atherosclerosis	6.96e-05	0.00274	CbGpPWpGaD
Metolazone—CA12—Metabolism—APOC3—atherosclerosis	6.94e-05	0.00273	CbGpPWpGaD
Metolazone—CA12—Metabolism—LDLR—atherosclerosis	6.9e-05	0.00271	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOA4—atherosclerosis	6.9e-05	0.00271	CbGpPWpGaD
Metolazone—CA4—Metabolism—BGN—atherosclerosis	6.79e-05	0.00267	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP7A1—atherosclerosis	6.77e-05	0.00266	CbGpPWpGaD
Metolazone—CA12—Metabolism—CETP—atherosclerosis	6.74e-05	0.00265	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOA5—atherosclerosis	6.72e-05	0.00264	CbGpPWpGaD
Metolazone—CA7—Metabolism—HMGCR—atherosclerosis	6.57e-05	0.00259	CbGpPWpGaD
Metolazone—CA5B—Metabolism—HMGCR—atherosclerosis	6.57e-05	0.00259	CbGpPWpGaD
Metolazone—CA4—Metabolism—PLA2G1B—atherosclerosis	6.47e-05	0.00254	CbGpPWpGaD
Metolazone—CA12—Metabolism—SCARB1—atherosclerosis	6.45e-05	0.00254	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—CXCL8—atherosclerosis	6.35e-05	0.0025	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ABCA1—atherosclerosis	6.28e-05	0.00247	CbGpPWpGaD
Metolazone—CA9—Metabolism—CYP27A1—atherosclerosis	6.26e-05	0.00246	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALOX5—atherosclerosis	6.25e-05	0.00246	CbGpPWpGaD
Metolazone—CA12—Metabolism—HMGCR—atherosclerosis	6.09e-05	0.0024	CbGpPWpGaD
Metolazone—CA9—Metabolism—PLA2G2A—atherosclerosis	5.94e-05	0.00233	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOA2—atherosclerosis	5.94e-05	0.00233	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALOX5AP—atherosclerosis	5.94e-05	0.00233	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALOX15—atherosclerosis	5.94e-05	0.00233	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCG5—atherosclerosis	5.86e-05	0.00231	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ABCA1—atherosclerosis	5.86e-05	0.0023	CbGpPWpGaD
Metolazone—CA7—Metabolism—ABCA1—atherosclerosis	5.86e-05	0.0023	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—NFKB1—atherosclerosis	5.68e-05	0.00223	CbGpPWpGaD
Metolazone—CA9—Metabolism—LPA—atherosclerosis	5.66e-05	0.00223	CbGpPWpGaD
Metolazone—CA4—Metabolism—NAMPT—atherosclerosis	5.6e-05	0.0022	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—MAPK8—atherosclerosis	5.58e-05	0.0022	CbGpPWpGaD
Metolazone—CA4—Metabolism—LIPC—atherosclerosis	5.57e-05	0.00219	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOC3—atherosclerosis	5.53e-05	0.00218	CbGpPWpGaD
Metolazone—SLC12A3—Transmembrane transport of small molecules—ALB—atherosclerosis	5.52e-05	0.00217	CbGpPWpGaD
Metolazone—CA4—Metabolism—LDLR—atherosclerosis	5.5e-05	0.00216	CbGpPWpGaD
Metolazone—CA9—Metabolism—BGN—atherosclerosis	5.48e-05	0.00216	CbGpPWpGaD
Metolazone—CA12—Metabolism—ABCA1—atherosclerosis	5.43e-05	0.00214	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOA5—atherosclerosis	5.43e-05	0.00214	CbGpPWpGaD
Metolazone—CA5A—Metabolism—HMOX1—atherosclerosis	5.39e-05	0.00212	CbGpPWpGaD
Metolazone—CA4—Metabolism—CETP—atherosclerosis	5.37e-05	0.00211	CbGpPWpGaD
Metolazone—CA9—Metabolism—PLA2G1B—atherosclerosis	5.23e-05	0.00206	CbGpPWpGaD
Metolazone—CA5A—Metabolism—APOB—atherosclerosis	5.16e-05	0.00203	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—VEGFA—atherosclerosis	5.15e-05	0.00203	CbGpPWpGaD
Metolazone—CA4—Metabolism—SCARB1—atherosclerosis	5.14e-05	0.00202	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—STAT3—atherosclerosis	5.1e-05	0.00201	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALOX5—atherosclerosis	5.05e-05	0.00198	CbGpPWpGaD
Metolazone—CA7—Metabolism—HMOX1—atherosclerosis	5.03e-05	0.00198	CbGpPWpGaD
Metolazone—CA5B—Metabolism—HMOX1—atherosclerosis	5.03e-05	0.00198	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GSTM1—atherosclerosis	5.02e-05	0.00197	CbGpPWpGaD
Metolazone—CA5A—Metabolism—LPL—atherosclerosis	4.93e-05	0.00194	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—MAPK3—atherosclerosis	4.88e-05	0.00192	CbGpPWpGaD
Metolazone—CA4—Metabolism—HMGCR—atherosclerosis	4.86e-05	0.00191	CbGpPWpGaD
Metolazone—CA7—Metabolism—APOB—atherosclerosis	4.82e-05	0.00189	CbGpPWpGaD
Metolazone—CA5B—Metabolism—APOB—atherosclerosis	4.82e-05	0.00189	CbGpPWpGaD
Metolazone—CA5A—Metabolism—GPX1—atherosclerosis	4.81e-05	0.00189	CbGpPWpGaD
Metolazone—CA7—Metabolism—GSTM1—atherosclerosis	4.68e-05	0.00184	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GSTM1—atherosclerosis	4.68e-05	0.00184	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CD36—atherosclerosis	4.68e-05	0.00184	CbGpPWpGaD
Metolazone—CA12—Metabolism—HMOX1—atherosclerosis	4.66e-05	0.00183	CbGpPWpGaD
Metolazone—CA5B—Metabolism—LPL—atherosclerosis	4.6e-05	0.00181	CbGpPWpGaD
Metolazone—CA7—Metabolism—LPL—atherosclerosis	4.6e-05	0.00181	CbGpPWpGaD
Metolazone—CA9—Metabolism—NAMPT—atherosclerosis	4.53e-05	0.00178	CbGpPWpGaD
Metolazone—CA9—Metabolism—LIPC—atherosclerosis	4.5e-05	0.00177	CbGpPWpGaD
Metolazone—CA7—Metabolism—GPX1—atherosclerosis	4.49e-05	0.00176	CbGpPWpGaD
Metolazone—CA5B—Metabolism—GPX1—atherosclerosis	4.49e-05	0.00176	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOC3—atherosclerosis	4.47e-05	0.00176	CbGpPWpGaD
Metolazone—CA12—Metabolism—APOB—atherosclerosis	4.46e-05	0.00175	CbGpPWpGaD
Metolazone—CA9—Metabolism—LDLR—atherosclerosis	4.44e-05	0.00175	CbGpPWpGaD
Metolazone—CA5A—Metabolism—MTHFR—atherosclerosis	4.43e-05	0.00174	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CD36—atherosclerosis	4.37e-05	0.00172	CbGpPWpGaD
Metolazone—CA7—Metabolism—CD36—atherosclerosis	4.37e-05	0.00172	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PPARA—atherosclerosis	4.35e-05	0.00171	CbGpPWpGaD
Metolazone—CA12—Metabolism—GSTM1—atherosclerosis	4.34e-05	0.00171	CbGpPWpGaD
Metolazone—CA9—Metabolism—CETP—atherosclerosis	4.34e-05	0.00171	CbGpPWpGaD
Metolazone—CA4—Metabolism—ABCA1—atherosclerosis	4.33e-05	0.0017	CbGpPWpGaD
Metolazone—CA12—Metabolism—LPL—atherosclerosis	4.26e-05	0.00168	CbGpPWpGaD
Metolazone—CA5A—Metabolism—AGT—atherosclerosis	4.21e-05	0.00166	CbGpPWpGaD
Metolazone—CA12—Metabolism—GPX1—atherosclerosis	4.16e-05	0.00163	CbGpPWpGaD
Metolazone—CA9—Metabolism—SCARB1—atherosclerosis	4.16e-05	0.00163	CbGpPWpGaD
Metolazone—CA5B—Metabolism—MTHFR—atherosclerosis	4.14e-05	0.00163	CbGpPWpGaD
Metolazone—CA7—Metabolism—MTHFR—atherosclerosis	4.14e-05	0.00163	CbGpPWpGaD
Metolazone—CA5A—Metabolism—APOE—atherosclerosis	4.13e-05	0.00162	CbGpPWpGaD
Metolazone—CA5A—Metabolism—CAV1—atherosclerosis	4.09e-05	0.00161	CbGpPWpGaD
Metolazone—CA5A—Metabolism—APOA1—atherosclerosis	4.08e-05	0.00161	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PPARA—atherosclerosis	4.06e-05	0.0016	CbGpPWpGaD
Metolazone—CA7—Metabolism—PPARA—atherosclerosis	4.06e-05	0.0016	CbGpPWpGaD
Metolazone—CA12—Metabolism—CD36—atherosclerosis	4.05e-05	0.00159	CbGpPWpGaD
Metolazone—CA5B—Metabolism—AGT—atherosclerosis	3.93e-05	0.00155	CbGpPWpGaD
Metolazone—CA7—Metabolism—AGT—atherosclerosis	3.93e-05	0.00155	CbGpPWpGaD
Metolazone—CA9—Metabolism—HMGCR—atherosclerosis	3.93e-05	0.00154	CbGpPWpGaD
Metolazone—CA5B—Metabolism—APOE—atherosclerosis	3.85e-05	0.00152	CbGpPWpGaD
Metolazone—CA7—Metabolism—APOE—atherosclerosis	3.85e-05	0.00152	CbGpPWpGaD
Metolazone—CA12—Metabolism—MTHFR—atherosclerosis	3.84e-05	0.00151	CbGpPWpGaD
Metolazone—CA7—Metabolism—CAV1—atherosclerosis	3.82e-05	0.0015	CbGpPWpGaD
Metolazone—CA5B—Metabolism—CAV1—atherosclerosis	3.82e-05	0.0015	CbGpPWpGaD
Metolazone—CA7—Metabolism—APOA1—atherosclerosis	3.81e-05	0.0015	CbGpPWpGaD
Metolazone—CA5B—Metabolism—APOA1—atherosclerosis	3.81e-05	0.0015	CbGpPWpGaD
Metolazone—CA12—Metabolism—PPARA—atherosclerosis	3.76e-05	0.00148	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PIK3CG—atherosclerosis	3.73e-05	0.00147	CbGpPWpGaD
Metolazone—CA4—Metabolism—HMOX1—atherosclerosis	3.71e-05	0.00146	CbGpPWpGaD
Metolazone—CA12—Metabolism—AGT—atherosclerosis	3.64e-05	0.00143	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PPARG—atherosclerosis	3.6e-05	0.00141	CbGpPWpGaD
Metolazone—CA12—Metabolism—APOE—atherosclerosis	3.57e-05	0.0014	CbGpPWpGaD
Metolazone—CA9—Cellular responses to stress—IL6—atherosclerosis	3.57e-05	0.0014	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOB—atherosclerosis	3.56e-05	0.0014	CbGpPWpGaD
Metolazone—CA12—Metabolism—CAV1—atherosclerosis	3.54e-05	0.00139	CbGpPWpGaD
Metolazone—CA12—Metabolism—APOA1—atherosclerosis	3.53e-05	0.00139	CbGpPWpGaD
Metolazone—CA5A—Metabolism—INS—atherosclerosis	3.53e-05	0.00139	CbGpPWpGaD
Metolazone—CA9—Metabolism—ABCA1—atherosclerosis	3.5e-05	0.00138	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PIK3CG—atherosclerosis	3.48e-05	0.00137	CbGpPWpGaD
Metolazone—CA7—Metabolism—PIK3CG—atherosclerosis	3.48e-05	0.00137	CbGpPWpGaD
Metolazone—CA4—Metabolism—GSTM1—atherosclerosis	3.46e-05	0.00136	CbGpPWpGaD
Metolazone—CA4—Metabolism—LPL—atherosclerosis	3.4e-05	0.00134	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PPARG—atherosclerosis	3.36e-05	0.00132	CbGpPWpGaD
Metolazone—CA7—Metabolism—PPARG—atherosclerosis	3.36e-05	0.00132	CbGpPWpGaD
Metolazone—CA4—Metabolism—GPX1—atherosclerosis	3.31e-05	0.0013	CbGpPWpGaD
Metolazone—CA7—Metabolism—INS—atherosclerosis	3.29e-05	0.00129	CbGpPWpGaD
Metolazone—CA5B—Metabolism—INS—atherosclerosis	3.29e-05	0.00129	CbGpPWpGaD
Metolazone—CA5A—Metabolism—ALB—atherosclerosis	3.23e-05	0.00127	CbGpPWpGaD
Metolazone—CA4—Metabolism—CD36—atherosclerosis	3.23e-05	0.00127	CbGpPWpGaD
Metolazone—CA12—Metabolism—PIK3CG—atherosclerosis	3.22e-05	0.00127	CbGpPWpGaD
Metolazone—CA12—Metabolism—PPARG—atherosclerosis	3.11e-05	0.00122	CbGpPWpGaD
Metolazone—CA5A—Metabolism—NOS3—atherosclerosis	3.09e-05	0.00122	CbGpPWpGaD
Metolazone—CA4—Metabolism—MTHFR—atherosclerosis	3.06e-05	0.0012	CbGpPWpGaD
Metolazone—CA12—Metabolism—INS—atherosclerosis	3.05e-05	0.0012	CbGpPWpGaD
Metolazone—CA5B—Metabolism—ALB—atherosclerosis	3.02e-05	0.00119	CbGpPWpGaD
Metolazone—CA7—Metabolism—ALB—atherosclerosis	3.02e-05	0.00119	CbGpPWpGaD
Metolazone—CA9—Metabolism—HMOX1—atherosclerosis	3e-05	0.00118	CbGpPWpGaD
Metolazone—CA4—Metabolism—PPARA—atherosclerosis	3e-05	0.00118	CbGpPWpGaD
Metolazone—CA4—Metabolism—AGT—atherosclerosis	2.91e-05	0.00114	CbGpPWpGaD
Metolazone—CA5B—Metabolism—NOS3—atherosclerosis	2.89e-05	0.00114	CbGpPWpGaD
Metolazone—CA7—Metabolism—NOS3—atherosclerosis	2.89e-05	0.00114	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOB—atherosclerosis	2.88e-05	0.00113	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOE—atherosclerosis	2.85e-05	0.00112	CbGpPWpGaD
Metolazone—CA5A—Metabolism—PTGS2—atherosclerosis	2.83e-05	0.00111	CbGpPWpGaD
Metolazone—CA4—Metabolism—CAV1—atherosclerosis	2.82e-05	0.00111	CbGpPWpGaD
Metolazone—CA4—Metabolism—APOA1—atherosclerosis	2.82e-05	0.00111	CbGpPWpGaD
Metolazone—CA9—Metabolism—GSTM1—atherosclerosis	2.8e-05	0.0011	CbGpPWpGaD
Metolazone—CA12—Metabolism—ALB—atherosclerosis	2.8e-05	0.0011	CbGpPWpGaD
Metolazone—CA9—Metabolism—LPL—atherosclerosis	2.75e-05	0.00108	CbGpPWpGaD
Metolazone—CA9—Metabolism—GPX1—atherosclerosis	2.68e-05	0.00105	CbGpPWpGaD
Metolazone—CA12—Metabolism—NOS3—atherosclerosis	2.68e-05	0.00105	CbGpPWpGaD
Metolazone—CA7—Metabolism—PTGS2—atherosclerosis	2.64e-05	0.00104	CbGpPWpGaD
Metolazone—CA5B—Metabolism—PTGS2—atherosclerosis	2.64e-05	0.00104	CbGpPWpGaD
Metolazone—CA9—Metabolism—CD36—atherosclerosis	2.61e-05	0.00103	CbGpPWpGaD
Metolazone—CA4—Metabolism—PIK3CG—atherosclerosis	2.57e-05	0.00101	CbGpPWpGaD
Metolazone—CA4—Metabolism—PPARG—atherosclerosis	2.48e-05	0.000975	CbGpPWpGaD
Metolazone—CA9—Metabolism—MTHFR—atherosclerosis	2.47e-05	0.000972	CbGpPWpGaD
Metolazone—CA12—Metabolism—PTGS2—atherosclerosis	2.45e-05	0.000962	CbGpPWpGaD
Metolazone—CA4—Metabolism—INS—atherosclerosis	2.43e-05	0.000957	CbGpPWpGaD
Metolazone—CA9—Metabolism—PPARA—atherosclerosis	2.42e-05	0.000954	CbGpPWpGaD
Metolazone—CA9—Metabolism—AGT—atherosclerosis	2.35e-05	0.000924	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOE—atherosclerosis	2.3e-05	0.000905	CbGpPWpGaD
Metolazone—CA9—Metabolism—CAV1—atherosclerosis	2.28e-05	0.000897	CbGpPWpGaD
Metolazone—CA9—Metabolism—APOA1—atherosclerosis	2.27e-05	0.000895	CbGpPWpGaD
Metolazone—CA4—Metabolism—ALB—atherosclerosis	2.23e-05	0.000877	CbGpPWpGaD
Metolazone—CA4—Metabolism—NOS3—atherosclerosis	2.13e-05	0.000839	CbGpPWpGaD
Metolazone—CA9—Metabolism—PIK3CG—atherosclerosis	2.08e-05	0.000817	CbGpPWpGaD
Metolazone—CA9—Metabolism—PPARG—atherosclerosis	2e-05	0.000788	CbGpPWpGaD
Metolazone—CA9—Metabolism—INS—atherosclerosis	1.97e-05	0.000773	CbGpPWpGaD
Metolazone—CA4—Metabolism—PTGS2—atherosclerosis	1.95e-05	0.000767	CbGpPWpGaD
Metolazone—CA9—Metabolism—ALB—atherosclerosis	1.8e-05	0.000709	CbGpPWpGaD
Metolazone—CA9—Metabolism—NOS3—atherosclerosis	1.72e-05	0.000678	CbGpPWpGaD
Metolazone—CA9—Metabolism—PTGS2—atherosclerosis	1.58e-05	0.00062	CbGpPWpGaD
Metolazone—CA5A—Metabolism—AKT1—atherosclerosis	1.42e-05	0.000559	CbGpPWpGaD
Metolazone—CA7—Metabolism—AKT1—atherosclerosis	1.33e-05	0.000522	CbGpPWpGaD
Metolazone—CA5B—Metabolism—AKT1—atherosclerosis	1.33e-05	0.000522	CbGpPWpGaD
Metolazone—CA12—Metabolism—AKT1—atherosclerosis	1.23e-05	0.000484	CbGpPWpGaD
Metolazone—CA4—Metabolism—AKT1—atherosclerosis	9.81e-06	0.000386	CbGpPWpGaD
Metolazone—CA9—Metabolism—AKT1—atherosclerosis	7.92e-06	0.000312	CbGpPWpGaD
